Back to Top Skip to main content Skip to sub-navigation

Military Health System participating in COVID-19 vaccine trial

Woman measuring out a vaccine into a needle Five military medical treatment facilities are participating in a Phase 3 clinical trial testing a COVID-19 vaccine in development with AstraZeneca. (Photo by Air Force Staff Sgt. Joshua Garcia.)

Recommended Content:

Coronavirus | COVID-19 Vaccine Efforts | COVID-19 Vaccine Toolkit | Vaccine Trials

Five military medical treatment facilities in the National Capital Region, Texas, and California are participating in a phase 3 clinical trial testing the AstraZeneca COVID-19 vaccine in development under Operation Warp Speed.  The DoD sites are actively enrolling study participants, with a goal to recruit up to 1,000 volunteers in each of the three market areas towards the total AstraZeneca clinical trial enrollment of 30,000 people.

Operation Warp Speed, a multiagency U.S. Government effort led by the Department of Health and Human Services and the Department of Defense, is working with the private sector with the aims to deliver safe and effective COVID-19 vaccine doses to the American public beginning January 2021.

OWS is funding clinical trials evaluating several vaccine candidates which were selected based on promising data on safety, immune response, and protection in animal studies and safety and immune response data in early-stage trials in humans. Each of the trials is designed to collect data on how well a vaccine candidate protects against COVID-19 and on the safety of the vaccine candidate in a larger population, including people most at risk.  

“The Department of Defense continues to play a key role in the development of a potential COVID-19 vaccine,” said Thomas McCaffery, assistant secretary of Defense for Health Affairs. “Now that vaccines have passed the first phases of testing for safety, dosing, and response, we have moved into the next phase where volunteers are needed to join large clinical studies. We are excited to have several sites supporting these next steps in the vaccine development process.”

Large phase 3 clinical trials are a necessary part of the rigorous scientific process to test the efficacy and safety of a vaccine in a real-world setting with a large population sample, said Air Force Col (Dr.) Jessica Cowden, chief medical officer of the DoD Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense Enabling Biotechnology Vaccine Acceleration Project.

“Phase 3 studies are designed to evaluate if the vaccine can prevent disease in the populations of people that the vaccine is being developed to protect,” said Cowden. “Phase 3 studies are large and usually involve some people who are at risk for infection and disease.”

The National Institute of Allergy and Infectious Diseases at the National Institutes of Health established a network of infectious disease experts and research partners, termed the Coronavirus Prevention Network, or CoVPN, to rapidly and thoroughly evaluate U.S. government-sponsored COVID-19 vaccines. The CoVPN website (https://www.coronaviruspreventionnetwork.org/) provides general information about products being developed to prevent COVID-19 and about clinical trials.

According to the CoVPN, interested volunteers must be adults aged 18 and older to be screened for these initial trials. The CoVPN recognizes the importance of including volunteers who are more likely to get COVID-19, such as those over the age of 65 or with underlying medical conditions; as well as people who work in an essential job, live in a densely populated area, or represent a racial and ethnic group greatly impacted by the epidemic.

Representation by such groups matters in Phase 3 trials because vaccines need to be tested in populations who are at most risk of being exposed to the disease and getting sick in the real world, explained Cowden. “At-risk populations shouldn’t bear a disproportionate burden of research, but they need to be represented,” she said

The selected DoD sites are currently enrolling volunteers for the AstraZeneca clinical trial, according to Cowden. The trial is a randomized control, double-blind study, meaning volunteers will either receive the study vaccine or saline. “The study team and the participant will be blinded so that they won’t know which the participant received until the end of the study,” Cowden said. AstraZeneca’s vaccine candidate is in late-stage clinical trials ongoing in the U.K., Brazil and South Africa.

“Participating in a vaccine clinical trial is voluntary but is also critically vital to ensure that the overall effort is ultimately successful,” said Dr. Sean Biggerstaff, acting deputy director, DHA Research and Development Directorate. “Volunteers should also know safety remains an overriding priority for anyone participating in clinical trials.”

Military health beneficiaries who wish to volunteer for the AstraZeneca COVID-19 vaccine at a nearby military medical treatment facility (or at a civilian site close to home) can contact the local study team directly to request more information or can register on the CoVPN website and consent to be contacted by a research team. If registering on the CoVPN site, interested volunteers should enter the appropriate code in parenthesis from the list below, or enter their ZIP code to join the registry. Site contact information is included here:

At this point, the DoD is only participating in the AstraZeneca study. Additional DoD sites are being prepared for participation in other clinical trials of vaccines and monoclonal antibodies to prevent COVID-19, said Cowden.

“Having a safe and effective COVID-19 vaccine is what we need to protect people and get life back to normal, but in order to get to that point, we have to do these clinical trials,” explained Cowden. “These big Phase 3 clinical trials with a lot of people participating are critical so we can get the information we need to determine if a vaccine candidate is safe and can prevent COVID-19.”

You also may be interested in...

Airway Pressure Release Ventilation (APRV) (April 17, 2020)

Video
5/11/2020
DHA Seal

This video will explain the basics of Airway Pressure Release Ventilation, an option for mechanical ventilation, that is helpful as an oxygen salvage therapy for patients with Acute Respiratory Distress Syndrome (ARDS).

Recommended Content:

Coronavirus | COVID-19 Vaccine Toolkit

Sedation and Analgesia in the ICU during COVID-19 (March 31, 2020)

Video
5/11/2020
DHA Seal

This video is intended to assist healthcare providers with the care of critically ill patients only. It is to be used as a guide ONLY for patients who have breathing tubes and are mechanically ventilated (on breathing machines). It will introduce you to sedative and analgesic medications that are used in the intensive care unit setting only. It will provide recommendations for use of sedation and analgesia in standard settings, but it will also provide recommendations for use in resource limited

Recommended Content:

Coronavirus | COVID-19 Vaccine Toolkit

Ventilator Basics - Part 2 (ACPC and PS) (March 25, 2020)

Video
5/11/2020
DHA Seal

This video is an introduction to pressure control and pressure support ventilator settings. If you have not yet viewed 'Vent Basics for Non-Intensivists (ACVC/VAC)", please watch that video first. This video is not intended to be all encompassing. It is intended to educate non-intensivists on basic vent settings and vent mechanics.

Recommended Content:

Coronavirus | COVID-19 Vaccine Toolkit

Acute Respiratory Distress Syndrome Lecture (April 10, 2020)

Video
5/11/2020
DHA Seal

In this lecture, the topic or Acute Respiratory Distress Syndrome is reviewed. Specific discussion on diagnosis and treatment including lung protective strategies are discussed.

Recommended Content:

Coronavirus | COVID-19 Vaccine Toolkit

IV Vasoactive Medication Basics for the Non Intensivist (March 19, 2020)

Video
5/11/2020
DHA Seal

This video provides a refresher/introduction to the basics of inotropes and vasopressors that may be helpful in the context of treating COVID-19 patients. It is not intended to be all-encompassing.

Recommended Content:

Coronavirus | COVID-19 Vaccine Toolkit

Ventilator Basics (ACVC) (March 19, 2020)

Video
5/11/2020
DHA Seal

Ventilator basics (one mode) for non-intensivists

Recommended Content:

Coronavirus | COVID-19 Vaccine Toolkit

Ventilator Tutorial V500/PB840 Drager (April 10, 2020)

Video
5/11/2020
DHA Seal

Ventilator assembly and input of settings for two common ICU ventilators.

Recommended Content:

Coronavirus | COVID-19 Vaccine Toolkit

Acid Base for the Non-intensivist (March 21, 2020)

Video
5/11/2020
DHA Seal

This video will teach you the etiologies for the various acid-base disorders as well as teach you how to interpret an ABG with a focus on metabolic acidosis and mixed disorders. This will teach you little to nothing about buffering, organic chemistry, biochemistry, etc. This is for practical application at the bedside.

Recommended Content:

Coronavirus | COVID-19 Vaccine Toolkit

ICU Nursing Series: Assembling Pressure Tubing (March 31, 2020)

Video
5/11/2020
DHA Seal

This video will review how to assemble pressure tubing to transduce pressures and waveforms from arterial lines and central lines. Connection to an ICU monitor with zeroing is also reviewed.

Recommended Content:

Coronavirus | COVID-19 Vaccine Toolkit

Sepsis In The Age of COVID-19 (April 10, 2020)

Video
5/11/2020
DHA Seal

This video will review diagnosis and management of sepsis with some clarifications/alterations that apply during the COVID pandemic. This video is not all inclusive. It is meant as a refresher for non-intensivists.

Recommended Content:

Coronavirus | COVID-19 Vaccine Toolkit

Awakening Trials, Breathing Trials, and Extubation (March 27, 2020)

Video
5/11/2020
DHA Seal

This video covers safety screens and failure criteria for Spontaneous Awakening Trials (SATs) and Spontaneous Breathing Trials (SBTs). These together form the ABCs of daily care of ICU patients on vents (Airway and Breathing Coordination). Additionally, it covers the criteria that should be met prior to attempting extubation.

Recommended Content:

Coronavirus | COVID-19 Vaccine Toolkit

A passion for helping and leading: Nurse leads Air Force Medical Service

Article
5/11/2020
Image of Lt. Gen. Dorothy Hogg

During her 36-year career in the Air Force, Hogg has climbed through the ranks and became the first nurse, as well as the first woman, to hold the position of Air Force surgeon general.

Recommended Content:

Coronavirus | Nurses Week

Nurses stay ready during COVID-19 pandemic

Article
5/11/2020
Image of two military nurses talking in a hospital hallway

MHS nurses go above and beyond the call of duty

Recommended Content:

Coronavirus | Nurses Week

The evolution of military nursing

Article
5/8/2020
Image of vintage military nurses

A look back on nurses who blazed the trail for nurses today

Recommended Content:

Coronavirus | Nurses Week

AFMES upgrades tech during COVID-19

Article
5/8/2020
Image of two technicians with a CT scanner machine

The new custom built scanner replaces a nearly 15-year-old scanner that was running on dated technology.

Recommended Content:

Armed Forces Medical Examiner System | Coronavirus
<< < ... 36 37 38 39 40  ... > >> 
Showing results 526 - 540 Page 36 of 42

DHA Address: 7700 Arlington Boulevard | Suite 5101 | Falls Church, VA | 22042-5101

Some documents are presented in Portable Document Format (PDF). A PDF reader is required for viewing. Download a PDF Reader or learn more about PDFs.